TTOO logo

T2 Biosystems, Inc. Stock Price

OTCPK:TTOO Community·US$308.5k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

TTOO Share Price Performance

US$0.011
-1.62 (-99.33%)
US$0.011
-1.62 (-99.33%)
Price US$0.011

TTOO Community Narratives

There are no narratives available yet.

Recent TTOO News & Updates

T2 Biosystems, Inc. Key Details

US$7.7m

Revenue

US$26.7m

Cost of Revenue

-US$19.0m

Gross Profit

US$23.9m

Other Expenses

-US$43.0m

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.53
Gross Margin
-247.83%
Net Profit Margin
-559.52%
Debt/Equity Ratio
-101.8%

T2 Biosystems, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

About TTOO

Founded
2006
Employees
113
CEO
Craig Jalbert
WebsiteView website
investors.t2biosystems.com

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.9%
  • 3 Months: 8.7%
  • 1 Year: 18.4%
  • Year to Date: 14.8%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 6.4%. Meanwhile, the market is actually up 18% over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›